FAP and glioblastoma: In our pilot study, 18 F-FAPI PET/CT detected 69.6% (16/23) of all lesions, which could be attributed to the varying FAP expressions in different molecular glioblastoma subtypes [37] or the status of the blood-brain barrier [19].